Neuraminidase inhibitor, oseltamivir blocks GM1 ganglioside-regulated excitatory opioid receptor-mediated hyperalgesia, enhances opioid analgesia and attenuates tolerance in mice

Brain Research

Volumn 995, Issue 2, 2004, Pages 260-266

  Crain, Stanley M ^a   Shen, Ke Fei ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Excitatory Gs coupled opioid receptors; Neuraminidase inhibitor; Opioid analgesia; Opioid hyperalgesia; Opioid tolerance

Indexed keywords

ANTIVIRUS AGENT; GLYCOLIPID; MONOSIALOGANGLIOSIDE; MORPHINE DERIVATIVE; OPIATE RECEPTOR; OSELTAMIVIR; SIALIDASE INHIBITOR;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; CONTROLLED STUDY; DRUG EFFECT; DRUG TOLERANCE; HYPERALGESIA; MALE; MODULATION; MOUSE; NERVE CELL; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

EID: 0346221268     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2003.09.068     Document Type: Article

References (38)

1. Crain S.M., Shen K.-F. Opioids can evoke direct receptor-mediated excitatory effects on sensory neurons. Trends Pharmacol. Sci. 11:1990;77-81.
2. Crain S.M., Shen K.-F. After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside. Brain Res. 575:1992;13-24.
3. Crain S.M., Shen K.-F. After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition. J. Pharmacol. Exp. Ther. 260:1992;182-186.
4. Crain S.M., Shen K.-F. Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10540-10544.
5. Crain S.M., Shen K.-F. Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions. Trends Pharmacol. Sci. 19:1998;358-365.
6. Crain S.M., Shen K.-F. GM1 ganglioside-induced modulation of opioid receptor-mediated functions. Ann. N.Y. Acad. Sci. 845:1998;106-125.
7. Crain S.M., Shen K.-F. Enhanced analgesic potency and reduced tolerance of morphine in 129/SvEv mice: evidence for a deficiency in GM1 ganglioside-regulated excitatory opioid receptor functions. Brain Res. 856:2000;227-235.
8. Crain S.M., Shen K.-F. Antagonists of excitatory opioid receptor functions enhance morphine's analgesic potency and attenuate opioid tolerance/dependence liability. Pain. 84:2000;121-131.
9. Crain S.M., Shen K.-F. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low naltrexone, unmasking potent opioid analgesia. Brain Res. 888:2001;75-82.
10. Doherty P., Walsh F.S. Ganglioside GM1 antibodies and B-cholera toxin bind specifically to embryonic chick dorsal root ganglion neurons but do not modulate neurite regeneration. J. Neurochem. 48:1987;1237-1244.
11. + conductance of DRG neurons and neuroblastoma×DRG neuron hybrid F11 cells. Brain Res. 696:1995;97-105.
12. Gubareva L.V., Kaiser L., Hayden F.G. Influenza virus neuraminidase inhibitors. Lancet. 355:2000;827-835.
13. Kim C.U., Lew W., Williams M.A., Liu H., Zhang L., Swaminathan S., Bischofberger N., Chen M.S., Mendel D.B., Tai C.Y., Laver W.G., Stevens R.C. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent anti-influenza activity. J. Am. Chem. Soc. 119:1997;681-690.
14. Kopitz J., von Reitzenstein C., Sinz K., Cantz M. Selective ganglioside desialylation in the plasma membrane of human neuroblastoma cells. Glycobiology. 6:1996;367-376.
15. Ledeen R.W. Gangliosides of the neuron. Trends in Neurosci. 8:1985;169-174.
16. Ledeen R.W. Biosynthesis, metabolism, and biological effects of gangliosides. Margolis R.V., Margolis R.K. Neurobiology of Glycoconjugates. 1989;43-83 Plenum, New York.
17. North R.A. Opioid receptor types and membrane ion channels. Trends Neurosci. 9:1986;114-117.
18. Powell K.J., Abul-Husn N.S., Jhamandas A., Olmstead M.C., Beninger R.J., Jhamandas K. Paradoxical effects of the opioid antagonist naltrexone on morphine analgesia, tolerance, and reward in rats. J. Pharmacol. Exp. Ther. 300:2002;588-596.
19. Rodriguez J.A., Piddini E., Hasegawa T., Miyagi T., Dotti C.G. Plasma membrane ganglioside sialidase regulates axonal growth and regeneration in hippocampal neurons in culture. J. Neurosci. 21:2001;8387-8395.
20. Scheideler M.A., Dawson G. Direct demonstration of the activation of UDP-N-acetylgalactosamine:[GM3]N-acetylgalactosaminyltransferase by cyclic AMP. J. Neurochem. 46:1986;1639-1643.
21. Shen K.-F., Crain S.M. Dual opioid modulation of the action potential duration of mouse dorsal root ganglion neurons in culture. Brain Res. 491:1989;227-242.
22. Shen K.-F., Crain S.M. Cholera toxin-B subunit blocks opioid excitatory effects on sensory neuron action potentials indicating that GM1 ganglioside may regulate Gs-linked opioid receptor functions. Brain Res. 531:1990;1-7.
23. Shen K.-F., Crain S.M. Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid "dependence" without tolerance. Brain Res. 597:1992;74-83.
24. Shen K.-F., Crain S.M. Nerve growth factor rapidly prolongs the action potential of mature sensory neurons in culture and this effect requires activation of Gs-coupled excitatory kappa opioid receptors on these cells. J. Neurosci. 14:1994;5570-5579.
25. Shen K.-F., Crain S.M. Ultra-low doses of naltrexone or etorphine increase morphine's antinociceptive potency and attenuate tolerance/dependence in mice. Brain Res. 757:1997;176-190.
26. Shen K.-F., Crain S.M. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opioid analgesia and attenuating opioid tolerance/dependence. Brain Res. 919:2001;20-30.
27. Shen K.-F., Crain S.M., Ledeen R.W. Brief treatment of sensory ganglion neurons with GM1 ganglioside enhances the efficacy of opioid excitatory effects on the action potential. Brain Res. 550:1991;130-138.
28. Shen K.-F., Crain S.M., Boston R., de Kater A., Moate P., Schoenhard G. PTI-555 reverses and prevents morphine-induced tolerance and naloxone-precipitated withdrawal in mice chronically treated with morphine. J. Pain. 3:2002;50.
29. Shen K.-F., Crain S.M., Moate P., Boston R., de Kater A., Schoenhard G. PTI-801, a novel formulation of oxycodone, shows absence of tolerance, physical dependence and naloxone-precipitated withdrawal effects in mice. J. Pain. 3:2002;49.
30. Suarez-Roca H., Maixner W. Activation of kappa opioid receptors by U50488H and morphine enhances the release of substance P from rat trigeminal nucleus slices. J. Pharmacol. Exp. Ther. 264:1993;648-653.
31. Suarez-Roca H., Maixner W. Morphine produces a biphasic modulation of substance P release from cultured dorsal root ganglion neurons. Neurosci. Lett. 194:1995;41-44.
32. Wieraszko A., Seifert W. The role of monosialoganglioside GM1 in the synaptic plasticity: in vitro study on rat hippocampal slices. Brain Res. 345:1985;159-164.
33. Wu G., Ledeen R.W. Stimulation of neurite outgrowth in neuroblastoma cells by neuraminidase: putative role of GM1 ganglioside in differentiation. J. Neurochem. 56:1991;95-104.
34. + currents. J. Neurosci. Res. 42:1995;493-503.
35. Wu G., Lu Z.-H., Ledeen R.W. GM1 ganglioside modulates prostaglandin E1 stimulated adenylyl cyclase in neuro-2A cells. Glycoconjugate J. 13:1996;235-239.
36. Wu G., Lu Z.-H., Ledeen R.W. Interaction of δ-opioid receptor with GM1 ganglioside: conversion from inhibitory to excitatory mode. Molec. Brain Res. 44:1997;341-346.
37. Wu G., Lu Z.-H., Tzongjer J.W., Howells R.D., Christoffers K., Ledeen R.W. The role of GM1 ganglioside in regulating excitatory opioid effects. Ann. N.Y. Acad. Sci. 845:1998;126-138.
38. von Reitzenstein C., Kopitz J., Schuhmann V., Cantz M. Differential functional relevance of a plasma membrane ganglioside sialidase in cholinergic and adrenergic neuroblastoma cell lines. Eur. J. Biochem. 268:2001;326-333.